Condition: Corneal Epithelial Wound Healing · Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
The objective of this study is to evaluate the safety and effectiveness of Lacripep as a therapy for superficial corneal injury repair after Photorefractive keratectomy (PRK).
This description comes directly from the study's public registry record.
Zachary P Skurski, DO · 571-231-1670 · Zachary.p.skurski.mil@health.mil
Rose Sia · rosekristine.c.sia.ctr@health.mil
Always discuss trial participation with your own doctor first.
| Alexander T. Augusta Military Medical Center | Fort Belvoir, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06854393